These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12220433)

  • 21. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
    Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
    Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difference of NPY and its receptor gene expressions between obesity and obesity-resistant rats in response to high-fat diet.
    Wang C; Yang N; Wu S; Liu L; Sun X; Nie S
    Horm Metab Res; 2007 Apr; 39(4):262-7. PubMed ID: 17447163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
    Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
    Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A G protein-coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1/Y5 receptor heterodimers.
    Kilpatrick LE; Humphrys LJ; Holliday ND
    Mol Pharmacol; 2015 Apr; 87(4):718-32. PubMed ID: 25637604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
    Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
    Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
    Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
    J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y stimulates food consumption through multiple receptors in goldfish.
    Narnaware YK; Peter RE
    Physiol Behav; 2001 Sep 1-15; 74(1-2):185-90. PubMed ID: 11564467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of neuropeptide Y (NPY) Y5 receptor-mediated obesity in mice: chronic intracerebroventricular infusion of D-Trp(34)NPY.
    Mashiko S; Ishihara A; Iwaasa H; Sano H; Oda Z; Ito J; Yumoto M; Okawa M; Suzuki J; Fukuroda T; Jitsuoka M; Morin NR; MacNeil DJ; Van der Ploeg LH; Ihara M; Fukami T; Kanatani A
    Endocrinology; 2003 May; 144(5):1793-801. PubMed ID: 12697685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of central feeding regulation by neuropeptide Y (NPY) neurons with NPY receptor small interfering RNAs (siRNAs).
    Higuchi H
    Neurochem Int; 2012 Nov; 61(6):936-41. PubMed ID: 22414532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness of obese Zucker rats to [D-Trp34]-NPY supports the targeting of Y5 receptor for obesity treatment.
    Beck B; Richy S; Stricker-Krongrad A
    Nutr Neurosci; 2007; 10(5-6):211-4. PubMed ID: 18284029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and pharmacological characterization of the neuropeptide Y receptor Y5 in the sea lamprey, Petromyzon marinus.
    Xu B; Sundström G; Kuraku S; Lundell I; Larhammar D
    Peptides; 2013 Jan; 39():64-70. PubMed ID: 23178200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations.
    Viiri LE; Loimaala A; Nenonen A; Islam S; Vuori I; Karhunen PJ; Lehtimäki T
    Atherosclerosis; 2005 Mar; 179(1):161-7. PubMed ID: 15721023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor.
    O'Shea D; Morgan DG; Meeran K; Edwards CM; Turton MD; Choi SJ; Heath MM; Gunn I; Taylor GM; Howard JK; Bloom CI; Small CJ; Haddo O; Ma JJ; Callinan W; Smith DM; Ghatei MA; Bloom SR
    Endocrinology; 1997 Jan; 138(1):196-202. PubMed ID: 8977404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in the 5'-flanking region of the neuropeptide Y2 receptor gene and metabolic parameters.
    Takiguchi E; Fukano C; Kimura Y; Tanaka M; Tanida K; Kaji H
    Metabolism; 2010 Nov; 59(11):1591-6. PubMed ID: 20359722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice.
    Kushi A; Sasai H; Koizumi H; Takeda N; Yokoyama M; Nakamura M
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15659-64. PubMed ID: 9861026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.